Tag : Astria Therapeutics

Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering
Fintech Investments News

Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering

Business Wire
Astria Therapeutics, Inc., a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced the pricing of an underwritten offering of (i) 8,253,895 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 6,190,418 shares of common stock, and (ii) to......
1